Here's the live share price of Choksi Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Choksi Laboratories has gained 62.56% CAGR. Over the past year, the corresponding return has been 2.85%.
Choksi Laboratories’s current P/E of 48.44x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Choksi Laboratories | -9.31 | -5.04 | -30.89 | -38.75 | 2.85 | 42.19 | 62.56 |
| Sun Pharma Advanced Research Company | -1.41 | -2.24 | 1.68 | -17.90 | -24.53 | -13.64 | -6.98 |
| Suven Life Sciences | -8.45 | -15.37 | -24.34 | -49.55 | 12.65 | 33.24 | 14.68 |
| Vimta Labs | -9.78 | -10.71 | -21.52 | 17.53 | 25.06 | 37.55 | 44.49 |
| Vanta Bioscience | 2.38 | 4.93 | -13.59 | -24.93 | -46.25 | -29.11 | -31.25 |
Over the last one year, Choksi Laboratories has gained 2.85% compared to peers like Sun Pharma Advanced Research Company (-24.53%), Suven Life Sciences (12.65%), Vimta Labs (25.06%). From a 5 year perspective, Choksi Laboratories has outperformed peers relative to Sun Pharma Advanced Research Company (-6.98%) and Suven Life Sciences (14.68%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 116.28 | 116.83 |
| 10 | 121.16 | 119.52 |
| 20 | 124.72 | 122.62 |
| 50 | 129.24 | 132.5 |
| 100 | 158.41 | 144.69 |
| 200 | 156 | 144.75 |
In the latest quarter, Choksi Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 5.69%, and public shareholding unchanged at 62.83% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Jan 10, 2026, 7:49 PM IST | Choksi Lab. Ltd - Announcement under Regulation 30 (LODR)-Resignation of Director |
| Jan 07, 2026, 11:06 PM IST | Choksi Lab. Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Nov 14, 2025, 9:46 PM IST | Choksi Lab. Ltd - Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025 |
| Nov 14, 2025, 9:42 PM IST | Choksi Lab. Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On 14.11.2025 |
| Nov 06, 2025, 6:05 AM IST | Choksi Lab. Ltd - Board Meeting Intimation for Board Meeting To Be Held On 14Th November, 2025 |
Choksi Laboratories Ltd. is a Public Limited Listed company incorporated on 29/01/1993 and has its registered office in the State of Madhya Pradesh, India. Company's Corporate Identification Number(CIN) is L85195MP1993PLC007471 and registration number is 007471. Currently company belongs to the Industry of Medical Research Services. Company's Total Operating Revenue is Rs. 41.78 Cr. and Equity Capital is Rs. 6.97 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Choksi Laboratories is ₹115.00 as on Jan 16, 2026.
The Choksi Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Choksi Laboratories is ₹80.10 Cr as on Jan 16, 2026.
Today’s highest and lowest price of Choksi Laboratories are ₹120.00 and ₹113.00.
The 52-week high/low is the highest and lowest price at which Choksi Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Choksi Laboratories is ₹236.70 and 52-week low of Choksi Laboratories is ₹97.55 as on Jan 16, 2026.
The Choksi Laboratories has shown returns of -1.29% over the past day, -5.04% for the past month, -30.89% over 3 months, 2.85% over 1 year, 42.19% across 3 years, and 62.56% over 5 years.
P/E ratio of and PB ratio of Choksi Laboratories are 48.44 and 3.27 on Jan 16, 2026. While the company gives a dividend yield of 0.00 per annum.